Rôle de la TEP dans la prise en charge des lymphomes primitifs du système nerveux central

Abstract

Primary central nervous system lymphoma is a rare but with growing incidence disease, especially in immunocompetent patients. Cerebral MRI is the gold standard imaging for diagnosis and monitoring of patients with cerebral lymphoma but 18F-FDG PET has an increasing use either for systemic evaluation according recent international recommendations or for characterizing brain lesion in initial staging. Other PET radiopharmaceuticals are being currently evaluated in research but may emerge in clinical practice in the coming years for differential diagnosis and therapeutic assessment.